WHC is still in active development. Read this to understand our approach.
depiction of SAADBVWGJQAEFS-UHFFFAOYSA-N.svg
tripsit

flurazepam

Verificar en tripsit

isomerdesign

Flurazepam

Verificar en isomerdesign

pubchem

Flurazepam

Verificar en pubchem

drugmap

Flurazepam

Verificar en drugmap

wiki

Flurazepam

Verificar en wiki

Data

InChI: InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3

Sinónimos: 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-,HSDB 3085,Felmane,Insumin, Somnol,617F231,UNII-IHP475989U,17617-23-1(free base),DEA No. 2767,FLURAZEPAM [JAN],Ro-5-6901/3, Felmane, Noctosom,DSSTox_CID_3071,7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one,2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-,7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one, Paxane, Flurazepam (JP15/INN),Tox21_112201,Ro 56901/3,17617-23-1, 7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one,ZINC537752,2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-,FLURAZEPAM [WHO-DD],DSSTox_RID_76863,Flurazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,FL7,CHEBI:5128, Valdorm,7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one, 7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one, Stauroderm,Dalmane, Ro-5-6901/3,Flurazepam 1.0 mg/ml in Methanol, Dalmane,Noctosom,Tox21_112201_1,FLURAZEPAM [HSDB], Insumin (TN), Flunox,FLURAZEPAM [VANDF], Dalmane-R, Flurazepam HCL,DSSTox_GSID_23071,Flurazepam-D4 solution, 100 mug/mL in methanol, certified reference material, Flurazepamum [INN-Latin], 2H-1,4-Benzodiazepin-2-one,7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride, Insumin,A812156,2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-1-(2-(DIETHYLAMINO)ETHYL)-5-(2-FLUOROPHENYL)-1,3-DIHYDRO,DB00690,7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one,SCHEMBL29793,BRN 0767925, 7-chloro-1-(2-diethylaminoethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one,Flurazepam HCL, 7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one,DB-044253,5-24-04-00322 (Beilstein Handbook Reference),7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one,9-Chloro-2-(2-diethylaminoethyl)-6-(2-fluorophenyl)-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-3-one,Insumin (TN),7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one #,7-chloranyl-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one,Dalmane-R,NCGC00164573-02,FLURAZEPAM [INN],D00329, Flurazepam hydrochloride, Flurazepamum,Flurazepamum,FLURAZEPAM [MI],Flurazepam 0.1 mg/ml in Methanol,2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-,CAS-17617-23-1,IHP475989U,Dalmadorm,Q418998,Flurazepamum [INN-Latin],(E)-7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one,DTXSID1023071,dalmane,7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one,Flurazepam,GTPL7188,Ro-56901, Dalmane (TN),Stauroderm,EINECS 241-591-7,AKOS015889971, Felison, Flurazepam [INN:BAN:JAN],flurazepam,NCGC00164573-01,7-CHLORO-1-(2-(DIETHYLAMINO)ETHYL)-5-(O-FLUOROPHENYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE,FLURAZEPAM [MART.],Flurazepam [INN:BAN:JAN],CHEMBL968,Flurazepam (JAN/INN), Dalmadorm (TN),7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

Estimated data

Solubilidad: -4.844 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 83.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.